Entera Bio Ltd. Liquidation Value Calculator
Entera Bio Ltd.
Current Price: N/A
Loading calculator data...
Advanced: All 81 XBRL Tags
Every XBRL tag from SEC EDGAR filings, grouped by financial statement type. total = may include children, fact = independent leaf value.
Balance Sheet
| Tag | Value | Unit | ||
|---|---|---|---|---|
| accounts_payable | ||||
| Accounts Payable Current total AccountsPayableCurrent |
$274,000 | USD | ||
| cash | ||||
| Cash And Cash Equivalents At Carrying Value total CashAndCashEquivalentsAtCarryingValue |
$4.14M | USD | ||
| AI Insight · Cash and cash equivalents of $4.1 million at March 31, 2026 recovers at 100% under liquidation. However, this figure must be read alongside RestrictedCashAndCashEquivalents of $7.9 million, of which $7.8 million is contractually designated for OPKO collaboration funding. The unrestricted, unencumbered cash position available to general creditors in a winding scenario is approximately $4.1 million plus the non-OPKO slice of restricted cash (~$0.1 million). This is the primary recovery asset. Cash declined from $14.97 million (beginning of period) as operating burn of $3.1 million exceeded financing inflows of $0.1 million in the quarter. | ||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents total CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents |
$12.02M | USD | ||
| Restricted Cash total RestrictedCash |
$7.79M | USD | ||
| Restricted Cash And Cash Equivalents total RestrictedCashAndCashEquivalents |
$7.88M | USD | ||
| AI Insight · Restricted cash and deposits total $7.9 million at March 31, 2026, compared to $8.1 million at March 31, 2025. Of this, $7.8 million is disclosed in MD&A as designated exclusively to fund obligations under the A&R Collaboration Agreement with OPKO. In a liquidation, these funds' status is contingent on contractual interpretation — if the agreement is terminated, a portion may be returnable to OPKO rather than available to equity. The filing does not separately XBRL-tag this OPKO-designated tranche, creating a risk of overstatement of freely available assets in any quick liquidation assessment. | ||||
| current_liabilities | ||||
| Operating Lease Liability Current total OperatingLeaseLiabilityCurrent |
$185,000 | USD | ||
| Other Accrued Liabilities Current total OtherAccruedLiabilitiesCurrent |
$455,000 | USD | ||
| liabilities_current | ||||
| Liabilities Current total LiabilitiesCurrent |
$1.58M | USD | ||
| liabilities_total | ||||
| Liabilities total | $2.44M | USD | ||
| operating_lease_liability | ||||
| Operating Lease Liability Current fact OperatingLeaseLiabilityCurrent |
$185,000 | USD | ||
| Operating Lease Liability Noncurrent fact OperatingLeaseLiabilityNoncurrent |
$263,000 | USD | ||
| AI Insight · Non-current operating lease liability of $0.3 million (plus $0.2 million current portion) totals $0.4 million in aggregate lease obligations. Under liquidation, ASC 842 lease liabilities do not extinguish — the full remaining obligation is a face-value claim. The corresponding ROU asset of $0.4 million receives zero recovery under the liquidation lens. Net effect is a $0.4 million negative contribution to equity recovery from the lease structure, which is relatively modest but material relative to the thin equity buffer. | ||||
| shares_outstanding | ||||
| Common Stock Shares Outstanding total CommonStockSharesOutstanding |
46.6M | shares | ||
Unmapped Tags (67)
| Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities | $1.12M | USD | ||
| Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock | $139.52M | USD | ||
| Assets Assets | $13.13M | USD | ||
| Assets Current AssetsCurrent | $12.49M | USD | ||
| Assets Noncurrent AssetsNoncurrent | $636,000 | USD | ||
| Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare | $0 | ILS/shares | ||
| Common Stock Shares Authorized CommonStockSharesAuthorized | $140.01M | shares | ||
| Common Stock Shares Issued CommonStockSharesIssued | $46.62M | shares | ||
| Common Stock Value CommonStockValue | $1,000 | USD | ||
| Defined Benefit Plan Assets For Plan Benefits Noncurrent DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent | $6,000 | USD | ||
| Deposits Assets Noncurrent DepositsAssetsNoncurrent | $90,000 | USD | ||
| Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity | $13.13M | USD | ||
| Liabilities Noncurrent LiabilitiesNoncurrent | $866,000 | USD | ||
| Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset | $413,000 | USD | ||
| Other Assets Current OtherAssetsCurrent | $256,000 | USD | ||
| Other Long Term Debt Noncurrent OtherLongTermDebtNoncurrent | $567,000 | USD | ||
| AI Insight · Non-current other long-term liabilities of $0.6 million represent the deferred collaboration component of the OPKO arrangement, recognized over the performance period per ASC 808. Under liquidation, this liability does not extinguish — the unperformed obligation would need to be settled or the consideration returned, effectively a face-value claim against assets. This is a new liability category that did not exist in the December 31, 2024 balance sheet and represents a direct consequence of the Q1 2025 OPKO transaction. Filing does not separately XBRL-tag the collaboration deferred revenue/liability line, referencing it only in narrative. | ||||
| Other Notes Payable Current OtherNotesPayableCurrent | $163,000 | USD | ||
| Property Plant And Equipment Net PropertyPlantAndEquipmentNet | $127,000 | USD | ||
| Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit | $-128.87M | USD | ||
| AI Insight · Accumulated deficit reached $128.9 million at March 31, 2026, increasing from $125.4 million at December 31, 2025 (a $3.5 million increase in one quarter). The deficit grew from $113.9 million at December 31, 2024 to $128.9 million at March 31, 2026 — a $15 million increase over 15 months driven entirely by operating losses with no revenue offset. This trajectory confirms the company is a pure cash-consumer. The deficit level relative to total assets ($13.1 million) illustrates that the equity buffer has been substantially eroded by cumulative losses. | ||||
| Stockholders Equity StockholdersEquity | $10.69M | USD | ||
| AI Insight · Total stockholders' equity of $10.7 million at March 31, 2026 declined from $13.1 million at December 31, 2025 and from $19.4 million at March 31, 2025. The year-over-year decline of $8.7 million reflects net losses partially offset by equity issuances. The equity base at book value approximates but does not exceed the liquidation recovery estimate when haircuts are applied to the asset side and the restricted cash encumbrance is considered — suggesting equity holders face near-zero or negative net recovery in a distressed wind-down scenario absent the post-period private placement proceeds. | ||||
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue | $672,000 | USD | ||
| Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition | $0 | USD | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect | $-2.96M | USD | ||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | $4,000 | USD | ||
| Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation | $313,000 | USD | ||
| Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable | $-174,000 | USD | ||
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities | $-2,000 | USD | ||
| Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets | $94,000 | USD | ||
| Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities | $130,000 | USD | ||
| Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities | $0 | USD | ||
| Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities | $-3.09M | USD | ||
| AI Insight · Operating cash outflow was $3.1 million in Q1 2026, more than double the $1.4 million outflow in Q1 2025. The acceleration is driven by increased R&D spend on EB613 Phase 3 preparation (+$0.4 million) and new OPKO collaboration costs (+$0.5 million net). At this Q1 2026 run rate, the unrestricted cash position of approximately $4.1 million would be exhausted in approximately 5-6 weeks without additional funding — confirming the going concern qualification and the company's dependence on the post-period April 2026 private placement. This burn rate is the primary driver of recovery risk. | ||||
| Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts | $0 | USD | ||
| Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment | $0 | USD | ||
| Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock | $0 | USD | ||
| Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised | $130,000 | USD | ||
| Proceeds From Warrant Exercises ProceedsFromWarrantExercises | $0 | USD | ||
| Share Based Compensation ShareBasedCompensation | $672,000 | USD | ||
| Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice | $2 | USD/shares | ||
| Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate | $0 | pure | ||
| Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate | $1 | pure | ||
| Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate | $0 | pure | ||
| Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax | $41,000 | USD | ||
| Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount | $17.32M | shares | ||
| Cost Of Revenue CostOfRevenue | $0 | USD | ||
| Earnings Per Share Basic EarningsPerShareBasic | $0 | USD/shares | ||
| Earnings Per Share Diluted EarningsPerShareDiluted | $0 | USD/shares | ||
| General And Administrative Expense GeneralAndAdministrativeExpense | $1.29M | USD | ||
| Gross Profit GrossProfit | $0 | USD | ||
| Labor And Related Expense LaborAndRelatedExpense | $435,000 | USD | ||
| Net Income Loss NetIncomeLoss | $-3.50M | USD | ||
| Nonoperating Income Expense NonoperatingIncomeExpense | $34,000 | USD | ||
| Operating Expenses OperatingExpenses | $3.54M | USD | ||
| Operating Income Loss OperatingIncomeLoss | $-3.54M | USD | ||
| Other Expenses OtherExpenses | $72,000 | USD | ||
| Other Labor Related Expenses OtherLaborRelatedExpenses | $1.25M | USD | ||
| Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent | $566,000 | USD | ||
| Prepaid Expense Current PrepaidExpenseCurrent | $310,000 | USD | ||
| Research And Development Expense ResearchAndDevelopmentExpense | $2.25M | USD | ||
| Revenues Revenues | $0 | USD | ||
| Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense | $128,000 | USD | ||
| Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent | $242,000 | USD | ||
| Accrued Vacation Current AccruedVacationCurrent | $211,000 | USD | ||
| Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts | $780,000 | USD | ||
| Depreciation Depreciation | $7,000 | USD | ||
| Number Of Operating Segments NumberOfOperatingSegments | $1 | Segment | ||
| Postemployment Benefits Liability Noncurrent PostemploymentBenefitsLiabilityNoncurrent | $36,000 | USD | ||
| Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised | $289,000 | USD | ||
Showing balance sheet tags only. Liquidation analysis uses balance sheet data.